Core Viewpoint - The establishment of the Sci-Tech Innovation Board (STAR Market) has significantly advanced the capital market's support for technological innovation in China, marking a major institutional innovation with the implementation of the registration system [1][2][3]. Group 1: Development and Achievements - Over the past six years, the STAR Market has raised over 1.1 trillion yuan through IPOs and refinancing, supporting 589 companies with a total market capitalization exceeding 7 trillion yuan [5][6]. - The board has seen the emergence of 8 companies with a market value exceeding 100 billion yuan, including SMIC and BeiGene, and 192 companies with a market value over 10 billion yuan [7]. - In 2024, more than 60% of companies on the board have introduced cash dividend plans totaling 38.8 billion yuan, with 290 companies having a dividend payout ratio exceeding 30% [9]. Group 2: Focus on Hard Technology - The STAR Market has become the preferred venue for "hard technology" companies, with over 80% of listed firms in strategic emerging industries such as information technology and biomedicine [11]. - The semiconductor sector has 120 companies along the industry chain, with SMIC as the leading player, while the biopharmaceutical sector has seen companies like Elysium and Zhenhua Cell grow significantly post-listing [11]. - The total R&D expenditure for the board in 2024 is projected to be 168 billion yuan, with a median R&D intensity of 12.6%, significantly higher than that of the main A-share market [11][12]. Group 3: Inclusivity and Policy Enhancements - The STAR Market has established a flexible listing standard that accommodates the unique development patterns of technology companies, allowing for 54 unprofitable companies and various special share structures [15][16]. - Recent reforms introduced by the CSRC aim to enhance inclusivity, including the establishment of a growth tier and the introduction of new measures to support unprofitable tech companies [18][19]. - Notable companies such as Changxin Storage and Yushu Technology are now seeking to initiate their listing processes, reflecting increased confidence among domestic tech firms [19].

2025年7月22日，科创板迎来开市6周年。 6年来，科创板上市公司数量已由首批挂牌上市的25家增至589家，IPO及再融资募资金额超1.1万亿元。 目前，超八成科创板公司为新一代信息技术、生物医药、高端装备制造等新兴产业公司，超八成公司核 心产品瞄准进口替代及自主可控，超380家公司的850余项产品或技术达到国际先进水平。 20家适用第五套标准上市的企业中，已有19家公司自研的45款药品/疫苗获批上市，其余1家公司产品上 市申请已获受理；16家公司营收超过1亿元，其中4家公司营收超过10亿元。2018年以来，科创板第五套 标准上市企业推出的1类新药数量约占同期国产创新药获批总数的12%，日益成长为我国医药创新的中 坚力量。 与此同时，作为改革"试验田"，科创板在发行、上市、交易、退市、再融资、并购重组等方面进行了一 系列制度创新，形成了可复制可推广的经验，为存量市场改革提供了有益借鉴。 有专家在接受《中国经营报》记者采访时总结道，科创板开市6周年以来，最大的成就是构建了一个 以"硬科技"为核心的资本市场平台，推动了科技创新与资本市场的深度融合。同时，科创板推动了资本 市场制度创新，为中国资本市场改革起到了示 ...

科创板今天（22日）迎来开市6周年。6年来，科创板以注册制改革为抓手，支持优质科技企业上市， IPO与再融资募集资金合计超1.1万亿元。记者从上海证券交易所了解到，截至7月22日，科创板累计支 持589家公司上市，IPO募集资金9257亿元，再融资募集资金1867亿元，总市值超过7万亿元。开市6年 来，科创板成为国内"硬科技"企业上市的首选地。上市公司高度聚集于高新技术产业和战略性新兴产 业，与 新质生产力发展方向高度契合。新一代信息技术、 生物医药、高端装备制造等新兴产业公司占 比超八成。 (央视新闻) ...

Core Viewpoint - The article discusses a significant escalation in military actions between Russia and Ukraine, highlighting the use of drones and missiles in recent attacks, and the impact on air travel in Moscow and St. Petersburg [1][2]. Summary by Sections Military Actions - Russian defense forces reported shooting down over 100 Ukrainian drones in various regions, including Moscow, during a recent 24-hour period [1]. - Ukraine's air force stated that Russia launched a large-scale attack using 426 drones and 24 missiles, marking the most extensive assault in the past week [1]. Impact on Air Travel - Due to the military actions, Moscow and St. Petersburg airports implemented air traffic control measures, resulting in 118 flight cancellations and 203 delays [1]. - A total of 59 flights were diverted to backup airports around Moscow within the same timeframe [1]. Defense Responses - As of the morning of the 21st, Ukrainian air defense intercepted 200 drones and most missiles, with 203 drones failing to hit their targets due to electronic warfare measures [2]. - Three locations in Ukraine were attacked by 23 drones, with 12 sites affected by debris from intercepted drones or missiles [2].

Group 1 - The core viewpoint of the news highlights that the hard technology sector is experiencing a cyclical turning point, with significant growth expected in various industries such as electronics, biotechnology, and intelligent manufacturing [1] - The electronic core industry accounts for 44.07% of the market capitalization, followed by the biotechnology industry at 15.92% and intelligent manufacturing equipment at 9.15% [1] - The semiconductor industry is entering a new upgrade cycle driven by AI, with increased demand due to the convergence of cloud and edge computing, as well as high-performance computing [1] Group 2 - The innovative drug industry is projected to achieve a breakthrough through License-out overseas, with a transaction scale expected to reach $51.9 billion in 2024, indicating a continuous growth trend [1] - Revenue growth rates for 2024 are forecasted at 17.39% for the electronic core industry, 28.44% for the artificial intelligence industry, and 32.36% for the biopharmaceutical industry, with significant profit expectations for the biopharmaceutical sector [1] - The R&D intensity of the Sci-Tech Innovation Board remains stable at a high level of 11%, with total R&D investment expected to reach 154.68 billion yuan in 2024, emphasizing the characteristics of innovation-driven development [1]

Core Viewpoint - The Sci-Tech Innovation Board (STAR Market) has successfully fostered high-quality development in China's capital market over the past six years, emphasizing innovation and the importance of "hard technology" in driving economic transformation [1][13]. Group 1: Market Development and Achievements - The STAR Market has grown from 25 initial companies to 589, generating an average of 2.5 patents per hour, particularly in sectors like semiconductors and biomedicine [1]. - The total IPO fundraising reached 925.7 billion yuan and 186.7 billion yuan in refinancing, exceeding 1.1 trillion yuan, significantly benefiting key strategic areas such as integrated circuits and biomedicine [3]. - The board has attracted 379 national-level "little giant" enterprises and 65 manufacturing "single champion" demonstration enterprises, accounting for 71% of the total companies listed [3]. Group 2: Institutional Innovations - The STAR Market has implemented over 20 key institutional rules to support technology innovation, including flexible listing standards and rapid refinancing mechanisms [7]. - The introduction of the "1+6" policy measures aims to enhance the board's inclusivity and adaptability for various types of hard technology enterprises [11][12]. Group 3: R&D and Innovation - In 2024, the total R&D investment of STAR Market companies reached 168 billion yuan, more than three times the net profit, with a median R&D investment ratio of 12.6% [4]. - Companies on the board have accumulated over 120,000 invention patents, with an average of 216 patents per company, showcasing a strong commitment to innovation [4]. Group 4: Talent and Collaboration - More than 60% of the founding teams of STAR Market companies are led by scientists, engineers, or industry experts, fostering a strong link between academia and industry [5]. - Nearly 30% of companies have core products aimed at achieving import substitution and self-control, indicating a focus on domestic innovation [5]. Group 5: Future Outlook - The STAR Market is positioned to continue its role as a "testbed" for reforms, with plans to attract more global innovation elements and support the development of new productive forces [13].

Group 1 - The core viewpoint of the article highlights the significant achievements of the Sci-Tech Innovation Board (STAR Market) in its six years, emphasizing its role as a "reform testbed" that has fostered the integration of technology and capital in China [1][3][21] - The STAR Market has nurtured nearly 600 innovative companies across key sectors such as semiconductors, biomedicine, new energy, and artificial intelligence, marking a historical transition of China's industrial chain from "catching up" to "leading" [3][11][21] - Over 60 companies on the STAR Market have launched globally innovative products, with 30% of companies having products or projects that are first-of-their-kind, showcasing the board's impact on fostering "hard technology" industries [6][21] Group 2 - The STAR Market has become a crucial platform for capital market reforms, with a focus on "hard technology," and has seen a significant increase in the number of institutional investors participating [21][27] - The introduction of various ETFs related to the STAR Market has provided investors with diversified investment tools, enhancing market liquidity and activity [6][8][21] - The STAR Market's reforms, including the registration system and the establishment of a growth tier, have improved the accessibility of capital for innovative companies, particularly in high-tech sectors [18][21][25] Group 3 - The article notes that the STAR Market has successfully transformed from a "testbed" for innovation to a "main battlefield" for China's technological self-reliance, with a focus on nurturing world-class tech companies [16][31] - The board's policies have led to a significant increase in R&D investment across the market, with a notable rise in the number of companies achieving breakthroughs in critical technologies [13][18][27] - Looking ahead, the STAR Market is expected to continue its role in supporting the development of high-quality tech enterprises and enhancing the synergy between technology, industry, and finance [19][31][34]

2025年7月22日，科创板迎来开市六周岁的生日。 作为我国资本市场改革的"试验田"和科技创新的核心枢纽，科创板六年来持续推动制度创新与产业升 级，成为全球瞩目的"硬科技"企业聚集地。 截至2025年7月22日，科创板上市公司达到589家。 科创板重点服务的战略新兴产业与新质生产力发展方向高度契合，新一代信息技术、生物医药、高端装 备制造等新兴产业公司占比超八成。经过六年的培育，科创板在集成电路、生物医药、新能源等重点产 业链形成示范和集聚效应，推动构建以行业"链主"为引领、上下游企业协同发展的矩阵式产业集群。 六年多来，上交所坚守科创板板块定位，深化各项制度机制创新，改革效应不断放大。特别是"科创板 八条"发布实施一年来，科创板改革"再出发"，服务科技创新和新质生产力发展的能力持续增强。 六年耕耘，科创板持续引领制度创新。 今年6月，"1+6"政策措施发布，统筹推进投融资综合改革和投资者权益保护，加快构建更有利于支持全 面创新的资本市场生态，揭开科创板新一轮改革序幕。 中信建投（601066）证券董事总经理董军峰在受访时表示，在科创板迈入"六年之期"的当口，设立"科 创成长层"及配套六项改革，标志着我国资本 ...

Core Viewpoint - The article emphasizes the significant achievements and ongoing evolution of the Sci-Tech Innovation Board (STAR Market) in China over the past six years, highlighting its role as a key driver for technological innovation and economic development in the country [1]. Group 1: Achievements of the Sci-Tech Innovation Board - As of June 2025, the STAR Market has successfully gathered over 580 high-quality technology companies, with a cumulative IPO financing scale exceeding 900 billion yuan, making it a crucial engine for the development of new productive forces in China [3][9][15]. - The STAR Market has become a primary platform for nurturing new productive forces, with over 80% of listed companies in emerging industries such as new-generation information technology, biomedicine, and high-end equipment manufacturing [5][9]. - The introduction of the STAR Market has led to significant capital market reforms, with the total market value of listed companies surpassing 8 trillion yuan and cumulative fundraising exceeding 1 trillion yuan [9][19]. Group 2: Institutional Innovations and Future Outlook - The STAR Market has implemented various institutional innovations, including the establishment of a growth tier to support unprofitable technology companies, enhancing the market's inclusivity and adaptability [12][24]. - The introduction of the "1+6" policy measures aims to further improve the STAR Market's support for technology innovation, optimizing the review mechanism and enhancing investor protection [10][24]. - Looking ahead, the STAR Market is expected to attract more international long-term capital and continue to play a pivotal role in the integration of technology, industry, and finance, contributing to high-quality economic development in China [10][11][19].

Core Viewpoint - The article celebrates the sixth anniversary of the Sci-Tech Innovation Board (STAR Market), highlighting its role as a "reform testbed" that has successfully integrated technology and capital, fostering a vibrant ecosystem for innovation in China [1][4]. Group 1: Development and Achievements - Over the past six years, the STAR Market has nurtured nearly 600 innovative companies, creating a robust ecosystem covering key sectors such as semiconductors, biomedicine, new energy, and artificial intelligence [4][8]. - The STAR Market has witnessed a significant transformation in China's industrial chain, evolving from "catching up" to "leading" in various sectors, with the STAR 50 Index reflecting this industrial upgrade [4][8]. - More than 60 companies on the STAR Market have launched globally innovative products, with 30% of companies having products or projects that are first-of-their-kind [8][20]. Group 2: Investment Opportunities - The growth of STAR Market-related ETFs has provided investors with efficient tools for participating in investment opportunities, enhancing market liquidity and activity [8][9]. - As of July 20, 2023, the total scale of STAR Market ETFs exceeded 260 billion yuan, accounting for about 9% of domestic A-share ETFs, indicating a strong interest in technology-themed investments [13][14]. - The article emphasizes the optimistic outlook for the technology growth sector in the A-share market, driven by advancements in artificial intelligence, innovative pharmaceuticals, and the overall recovery of market risk appetite [14][40]. Group 3: Future Prospects - The STAR Market is expected to cultivate more global industry leaders and witness original breakthroughs, particularly in the context of increasing global competition in technology [5][21]. - The introduction of the "1+6" reform policies is seen as timely, aligning with the emergence of strategic companies in key technology sectors, which may drive strong momentum for the STAR Market [21][37]. - The article suggests that the STAR Market will continue to deepen reforms and support the development of world-class Chinese technology companies, contributing to the country's goal of achieving high-level technological self-reliance [46][48].